Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0222
0.00 (0.00%)
May 2, 2025, 10:22 AM EDT

Galera Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
23842121255
Upgrade
Market Cap Growth
-56.28%-56.28%-81.38%-65.01%-52.46%-21.82%
Upgrade
Enterprise Value
149146131-033167
Upgrade
Last Close Price
0.020.050.151.494.5910.23
Upgrade
PB Ratio
-0.01-0.02-0.06-0.39-2.0941.72
Upgrade
P/TBV Ratio
-----85.68
Upgrade
Debt / Equity Ratio
-1.05-1.05-1.16-1.28-2.210.09
Upgrade
Quick Ratio
5.365.363.682.605.515.21
Upgrade
Current Ratio
6.006.004.362.885.985.58
Upgrade
Return on Equity (ROE)
------196.02%
Upgrade
Return on Assets (ROA)
-48.81%-48.81%-83.63%-50.28%-54.78%-42.51%
Upgrade
Return on Capital (ROIC)
-62.09%-62.09%-113.71%-63.49%-119.08%-114.40%
Upgrade
Earnings Yield
-1131.58%-548.28%-747.06%-146.53%-66.36%-29.08%
Upgrade
FCF Yield
--351.26%-567.82%-102.32%-56.23%-23.50%
Upgrade
Buyback Yield / Dilution
-22.64%-22.63%-64.47%-5.03%-3.70%-586.06%
Upgrade
Updated Dec 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.